glp-1 weight loss non diabetic cost McKee's proposed FY2027 budget drops drugs for from Medicaid • Rhode Island Current Benefits of GLP-1s outweigh harms

Glucagon receptor engagement may augment energy expenditure and fat oxidation, potentially complementing GLP1/GIPmediated appetite and glycemic effects

PlexusDx compounded medications from licensed 503A pharmacies, paired with genetic and biomarker insights, enable a truly precision-guided conversation with your healthcare team about safety and efficacy for your specific situation

And there is no clear path forward for GLP-1 coverage in Medicare after 2027 if the Medicare GLP-1 Bridge is not extended further and the BALANCE Model is not implemented

We're continuing to keep a close eye on the progress of this litigation